Vijaya Diagnostic Centre Ltd

Vijaya Diagnost. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vijaya Diagnostic Centre Ltd

₹ 676 -2.28%
18 Apr - close price
vijayadiagnostic.com BSE: 543350 NSE : VIJAYA
About

Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine, radiology, laboratory, health check-ups and medical services. The company provides its services across 13 cities through its 81 diagnostic centers and 11 reference laboratories.[1]

Key Points

Largest Diagnostic Chain in Southern India [1]
Vijaya Diagnostic Center Ltd. (VDCL) is the largest integrated diagnostic chain in South India, by revenue and also one of the fastest-growing diagnostic chains by revenue for FY23.

Website BSE NSE
  • Market Cap ₹ 6,922 Cr.
  • Current Price ₹ 676
  • High / Low ₹ 719 / 349
  • Stock P/E 60.5
  • Book Value ₹ 58.3
  • Dividend Yield 0.15 %
  • ROCE 18.4 %
  • ROE 16.6 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Stock is trading at 11.6 times its book value
  • Promoter holding has decreased over last quarter: -0.81%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
100 112 123 113 111 116 104 121 113 121 121 139 133
53 58 66 62 63 68 64 72 69 72 73 82 80
Operating Profit 46 54 57 51 48 48 40 49 44 49 48 57 52
OPM % 46% 49% 46% 45% 43% 41% 38% 40% 39% 41% 40% 41% 39%
3 4 3 3 3 3 3 3 4 5 6 7 3
Interest 4 3 4 4 4 4 5 5 6 6 6 6 6
Depreciation 12 13 12 12 13 15 14 16 20 11 12 14 15
Profit before tax 33 43 44 38 34 31 24 31 22 36 35 45 35
Tax % 25% 26% 25% 26% 25% 24% 26% 25% 25% 24% 26% 25% 25%
25 32 33 28 25 24 18 23 16 28 26 34 26
EPS in Rs 54.57 6.93 3.23 2.72 2.48 2.33 1.71 2.29 1.60 2.69 2.57 3.26 2.53
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
251 293 339 377 462 459 514
171 184 206 211 259 277 307
Operating Profit 80 108 133 166 204 182 207
OPM % 32% 37% 39% 44% 44% 40% 40%
7 10 15 12 13 14 20
Interest 5 14 15 15 16 21 24
Depreciation 26 40 49 50 53 62 52
Profit before tax 55 65 83 112 147 114 151
Tax % 37% 29% 25% 24% 25% 25%
35 46 63 85 111 85 114
EPS in Rs 77.44 101.29 138.00 18.64 10.76 8.29 11.05
Dividend Payout % 0% 0% 0% 0% 9% 12%
Compounded Sales Growth
10 Years: %
5 Years: 13%
3 Years: 11%
TTM: 13%
Compounded Profit Growth
10 Years: %
5 Years: 19%
3 Years: 13%
TTM: 41%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 79%
Return on Equity
10 Years: %
5 Years: 23%
3 Years: 22%
Last Year: 17%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 5 5 5 5 10 10 10
Reserves 157 203 270 354 458 535 587
33 146 161 141 183 248 253
39 53 46 41 62 61 76
Total Liabilities 234 406 482 541 713 853 926
119 259 272 268 370 524 570
CWIP 3 3 10 9 34 28 15
Investments 73 69 55 28 54 139 195
39 76 146 236 255 163 145
Total Assets 234 406 482 541 713 853 926

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
62 91 106 130 158 165
-98 -90 -31 -130 -123 -110
-8 -7 -30 -49 -31 -42
Net Cash Flow -44 -6 46 -49 4 13

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 12 11 9 6 8 8
Inventory Days 24 20 23 17 22 13
Days Payable 176 196 180 142 110 172
Cash Conversion Cycle -140 -165 -149 -118 -81 -152
Working Capital Days -41 -40 -38 -15 -23 -25
ROCE % 28% 23% 27% 28% 18%

Shareholding Pattern

Numbers in percentages

4 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
54.78% 54.78% 54.78% 55.04% 55.01% 55.01% 55.01% 54.98% 54.90% 54.87% 54.06%
23.36% 26.37% 28.12% 27.99% 23.89% 24.96% 25.28% 20.27% 20.68% 19.95% 20.09%
15.89% 14.97% 13.08% 12.81% 15.77% 14.22% 13.90% 19.02% 18.64% 19.82% 20.80%
5.97% 3.88% 4.02% 4.16% 5.33% 5.79% 5.81% 5.73% 5.78% 5.36% 5.03%
No. of Shareholders 1,20,57082,13979,02177,22976,98579,05976,53273,85072,79566,20466,724

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls